Recently Completed and Current Studies
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life (PACE-Life)
PI: David Penn, Ph.D. and Claudio Battaglini, Ph.D.
Funded by: NIH/NIMH
The objective in this application to conduct an open trial, followed by a small RCT, comparing PACE-Life intervention and using a Fitbit to the Fitbit only control condition for 56 individuals with schizophrenia spectrum disorders. We are currently in the recruitment phase of this trial which has an expected completion date of 2021.
Targeting Stress Reactivity in Schizophrenia: Integrating Coping Awareness Therapy (I-CAT)
PI: Piper Meyer, Ph.D., David Penn, Ph.D. and Diana Perkins, M.D.
Funded by: NIMH
The purpose of this study is to develop and then subsequently evaluated a mindfulness/positive therapy intervention for individuals with first episode psychosis. Following a manual development period, an open trial of six clients was conducted, which has lead to a small-scale RCT (n=40). The study was completed in January 2020, and we are currently in the data analysis phase of this trial.
Enhancing Recovery for Individuals with First Episode Psychosis: The Horyzons Project
PIs: David Penn, Ph.D., Mario Alvarez, Ph.D., Diana Perkins, M.D., and John Gleeson, Ph.D.
Funded by: Unrestricted gift from Australian Catholic University to UNC
The purpose of this study is to test the feasibility and preliminary benefits of an innovative online behavioral intervention, Horyzons, for individuals with first episode psychosis in the United States. The research is being conducted in collaboration with Drs. Alvarez and Gleeson at Orygen and ACU, and is funded by the state of North Carolina.
Black Americans with Schizophrenia Study (BASS)
PIs: David Penn, Ph.D., Arun Nagendra, Ph.D.
The BASS study was designed as a follow up to this project, to examine how race-related factors influence social cognition among Black American women. While data analysis is still on-going for this project, initial analyses were conducted with a sub-sample to investigate how experimenter race and perceived discrimination impacted social cognitive performance among healthy Black women, as well as the mediating effects of physiological reactivity. Future analyses will continue to investigate how physiological reactivity (e.g., heart rate variability, blood pressure) and other risk and resilience factors (e.g., racial identity, social defeat, subclinical paranoia, etc.) may affect Black women’s social cognitive performance in the context of White vs. Black experimenters.
How Often Do US-Based Schizophrenia Papers Published in High-Impact Psychiatric Journals Report on Race and Ethnicity?: An 20-Year Update of Lewine and Caudle (1999) (2020). Journal of Mental Health, DOI 10.1080/09638237.2020.1837356.
- Racial and ethnic disparities have been clearly documented in schizophrenia studies, but it is unclear how much research attention they receive among US-based studies published in high-impact journals. This project updates Lewine and Caudle (1999) and Chakraborty and Steinhauer (2010), which quantified how frequently schizophrenia studies included information on race and ethnicity in their analyses.
As a follow-up to the above project, the Author Race project seeks to examine the demographic composition of authors publishing articles on psychosis in high-impact journals. We believe the lack of schizophrenia-related research reporting on race and ethnicity may be in part explained by a lack of diversity amongst schizophrenia researchers; thus, this project seeks to examine the race, gender, and ethnicity of these researchers.